Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: A double-blind, placebo-controlled, randomised clinical trial
Alemany, A., Millat-Martinez, P., Corbacho-Monné, M., Suñer, C., Galvan-Casas, C., Carrera, C., Vidal-Alaball, J., Clotet, B., Mitjà, O., . . … Read More
